SCHEMBL22904149

SCHEMBL22904149

Cc1ccccc1-n1ncc2c1C(=O)NC(=O)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
GSK3B P49841 2/20 0.43
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
GRIA1 P42261 2/20 0.40
CACNG8 Q8WXS5 2/20 0.40
CASP3 P42574 2/20 0.40
CASP6 P55212 2/20 0.40
TDP2 O95551 1/20 0.40
CASP7 P55210 1/20 0.40
CASP9 P55211 1/20 0.40
CASP8 Q14790 1/20 0.40
MAP3K14 Q99558 1/20 0.40
HDAC9 Q9UKV0 2/20 0.39
ALOX5 P09917 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK14 Q16539 1/20 0.38
PDE9A O76083 1/20 0.38
HIF1A Q16665 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22904139 0.71 KDR (0.34) KDR
SCHEMBL22904120 0.70 MAPT (0.47) MAPTDDB1CRBNGRIA1CACNG8
SCHEMBL22904142 0.69 MEN1 (0.46) MAPTGSK3BDDB1CRBNCASP3
SCHEMBL12783240 0.68 KMT2A (0.45) MAPTGSK3BDDB1CRBNGRIA1
SCHEMBL11942169 0.67 MAPK14 (0.38) MAPTHDAC9KMT2AMEN1MAPK14
SCHEMBL18850703 0.65 HDAC9 (0.46) HDAC9KMT2AMAPK14ALDH1A1
SCHEMBL22904122 0.65 MAPT (0.47) MAPTGSK3BDDB1CRBNGRIA1
SCHEMBL6238897 0.64 MAPT (1.00) MAPTDDB1CRBNCASP3CASP6
SCHEMBL13990279 0.64 KMT2A (0.48) MAPTGSK3BKMT2AMEN1MAPK14
SCHEMBL20886849 0.63 TDP2 (0.64) MAPTGRIA1CACNG8CASP3CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed